Does have autologous blood withdrawal pre-operative with and without sequestration, effect on the usage of allogeneic bloodproducts during and after heartsurgery.

Does have autologous blood withdrawal pre-operative with and without sequestration, effect on the usage of allogeneic bloodproducts during and after heartsurgery. - Sequestration Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33597

Enrollment

102

Registered

2009-05-12

Start date

2009-07-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Need for blood transfusion during and after open heart surgery

Interventions

Group 1. autologous blood withdrawal and return transfusion. Group 2. autologous blood withdrawal with sequestration and return transfusion. Group 3. control group

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults age >= 18 year, undergoing openheartsurgery for CABG and or valve surgery BSA > 170 dm2 Hemoglobin/Hematocrit >= 0,20 L/L

Exclusion criteria

Exclusion criteria: Pre-operative Total Trombocytes = 2,5 x ULN NYHA Class III and IV Severe impaired renal function: Creatinine > 120 umol/l Re operation COPD

Design outcomes

Primary

Measure	Time frame
Is there a decrease in use of allogeneic blood products in the sequestration group?	—

Secondary

Measure	Time frame
Is there a decrease of blood loss in the sequestration group in regards to the blood loss of the other two groups?	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)